Company research

ELEVANCE HEALTH INC FORMERLY

ELV

Current Tracked Holders
3
One-Year Insider Activity
Purchases 5 $2.6M
Sales 5 $1.7M

Price history

Price history loads when this section approaches view.

Quarter-End Change Analysis

No published quarterly analysis yet

Reviewed research will appear here when it is published.

Current reported holders

Portfolio ManagerRecent activitySharesValuePortfolio
Glenn GreenbergBrave Warrior Advisors, LLC
ELVReduced
1,122,308
$328,556,000
8.13%
Seth KlarmanBaupost Group LLC/MA
ELVAdded
1,275,154
$373,301,000
7.30%
Ruane, Cunniff & Goldfarb L.P.
ELVReduced
1,387,968
$406,328,000
6.74%

Long-term company research

Fundamental analysis

Research pending

Fundamental research pending

Reviewed company research will appear here when available.

Financial data loads when this section approaches view.

Insider activity

One-year insider activity

Open-market purchases and sales only.

Checked 2026-08-11
DateInsiderTypeSharesPriceValueSource
2026-07-17BOUDREAUX GAILDirector, President and CEOPurchase680$366$249,159SEC ↗
2026-07-17BOUDREAUX GAILDirector, President and CEOPurchase2,045$368$753,071SEC ↗
2026-07-17PERU RAMIRO GDirectorPurchase1,000$366$366,050SEC ↗
2026-06-12Penczek Ronald WCAO & ControllerSale369$403$148,766SEC ↗
2026-06-11Dixon Robert L JRDirectorSale151$402$60,667SEC ↗
2026-05-19Penczek Ronald WCAO & ControllerSale1,531$403$617,192SEC ↗
2026-03-12SCHULMAN AMY WDirectorSale26$288$7,475SEC ↗
2026-03-06Kendrick Charles Morgan JREVP & President, CommercialSale3,196$285$910,604SEC ↗
2026-03-05COLLIS STEVEN HDirectorPurchase3,000$290$869,520SEC ↗
2025-08-19DeVore Susan D.DirectorPurchase1,200$312$374,580SEC ↗